Pharmaceuticals, health and wellness

Sanofi’s Dupixent scores big as the first FDA-approved treatment for eosinophilic esophagitis zbecker Fri, 05/20/2022 – 15:45 Source link

Sanofi’s Xenpozyme, Lilly’s Olumiant among batch of new EU approvals kdunleavy Fri, 05/20/2022 – 10:54 Source link

Fierce Pharma Asia—Hengrui’s global plan; Merck, Kelun’s $1.4B cancer deal; Dr. Reddy’s Russia business aliu Fri, 05/20/2022 – 06:18 Source link

Troubles for Bayer and AbbVie? Their market cap in Q1 tells a different story: report kdunleavy Thu, 05/19/2022 – 07:03 Source link

‘Startup like no other’: China’s Hengrui launches Luzsana with Big Pharma veterans at the top and a goal to improve drug access aliu Wed, 05/18/2022 – 05:32 Source link

3rd time lucky? ScPharmaceuticals gets decision date for twice-rejected on-body drug delivery product ntaylor Tue, 05/17/2022 – 09:26 Source link

Otsuka drops beleaguered Akebia after FDA snub. Will AstraZeneca follow suit with FibroGen? aliu Mon, 05/16/2022 – 08:49 Source link

Lilly’s highly anticipated diabetes drug Mounjaro wins FDA blessing kdunleavy Fri, 05/13/2022 – 17:26 Source link

Trial for controversial China-made Alzheimer’s drug aborted as capital raise hits snag, COVID hurts sales aliu Fri, 05/13/2022 – 15:58 Source link

Bristol Myers sells NY biologics plant for $160M to fuel Lotte’s drugmaking ambitions fkansteiner Fri, 05/13/2022 – 08:41 Source link

Seagen CEO’s arrest came during a hazy night of booze, sex and violence: police report kdunleavy Wed, 05/11/2022 – 18:21 Source link

FDA converts emergency nod for Lilly’s Olumiant to a full approval for hospitalized COVID patients kdunleavy Wed, 05/11/2022 – 09:00 Source link